AdjuderaGet started

Awarded

RYSTIGGO 140 MG/ML SOLUCION INYECTABLE, 1 vial de 3 ml

Original language: Spanish

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
Buyer
HOSPITAL CLINICO SAN CARLOS
Winners
UCB PHARMA, S.A
Contract value
€296,836
Bids received
1
Published
3 Sept 2026
Awarded
28 Aug 2026
Contract start
28 Aug 2026
Contract end
14 Sept 2027estimated
Sector
Medical equipment and pharmaceuticals
Region
Madrid
Source
Original notice on TED (611222-2026)

More awards from this buyer

AwardedBuyerWinnerContract valuePublished
ATOGEPANT (AQUIPTA 60 mg comprimidos 28 comprimidos)HOSPITAL CLINICO SAN CARLOSABBVIE SPAIN, S.L€243,58828 Oct 2026
ATOGEPANT (AQUIPTA 10 mg comprimidos 28 comprimidos)HOSPITAL CLINICO SAN CARLOSABBVIE SPAIN, S.L€12,99128 Oct 2026
FILSPARI 400 MG COMPRIMIDOS 30 comprimidosHOSPITAL CLINICO SAN CARLOSVIFOR PHARMA ESPAÑA S.L.€253,39428 Oct 2026
FILSPARI 200 MG COMPRIMIDOS 30 comprimidosHOSPITAL CLINICO SAN CARLOSVIFOR PHARMA ESPAÑA S.L.€9,70428 Oct 2026
2ª prorroga RINGER LACTADO SOLUCIÓN ESTÉRIL Y APRIRÓGENA EN AGUA PARA INYECCIÓN FRASCO PLÁSTICO SEMIRRÍGIDO O BOLSA PLASTICOHOSPITAL CLINICO SAN CARLOSFRESENIUS KABI ESPAÑA, S.A.€17,39023 Oct 2026
2ª prorroga GLUCOSALINO SOLUCIÓN ESTÉRIL Y APRIRÓGENA EN AGUA PARA INYECCIÓN ADMINISTRACIÓN IV FRASCO PLÁSTICO SEMIRRÍGIDO O BOLSA PLASTICOHOSPITAL CLINICO SAN CARLOSFRESENIUS KABI ESPAÑA, S.A.€4,88023 Oct 2026